synthetic genomics
Twist Bioscience Q2 Revenues Grow 62 Percent
The synthetic DNA manufacturer missed the consensus Wall Street estimate for loss per share but beat analysts' estimate on the top line.
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick
The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules.
In addition to discussing Twist's liquid biopsy, NGS-based genotyping and SARS-CoV-2 NGS panel, CEO Emily Leproust touted efforts on DNA data storage.Â
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Nov 23, 2020
Aug 6, 2020
Twist Bioscience Q3 Revenues Grow 56 Percent
Jun 4, 2020
Twist Bioscience Prices $100M Stock Offering
May 21, 2020
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Jan 7, 2020
Dec 12, 2019
Oct 10, 2019
Oct 2, 2019